Delivery Order SPE2DR25D1109-SPE2DR26FFH4U
- Not listed
- The Defense Logistics Agency awarded a $1,679.80 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Durolane 60 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is expected to be completed by December 4, 2025, with fulfillment occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $10,514.15. This non-competitive, firm fixed-price delivery order is set to be completed by December 11, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $42,095.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Durolane 60mg/3ml injections. This is a non-set-aside contract with a completion date of January 7, 2026, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999 and runs through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,275.20 firm fixed-price delivery order for Durolane 60 mg/3 ml syringes on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-competitive, non-set-aside award is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $5,495.41 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,785.01 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $12.7K under firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH4UDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,565.96 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on December 5, 2025, with a completion date of December 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's $999.99 billion indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support contract for military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies an extensive portfolio of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Durolane product—an injectable hyaluronic acid preparation used for joint pain management—falls within the company's established medical supply capabilities and supports the DLA's mission to provision military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/4/25 |